Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.
暂无分享,去创建一个
Thomas Laurell | Charlotte Welinder | Johan Malm | Melinda Rezeli | György Marko-Varga | Akos Végvári | Hans Lilja | H. Lilja | J. Malm | G. Marko‐Varga | T. Laurell | Á. Végvári | M. Rezeli | C. Welinder
[1] R. Gittes,et al. Prostate-specific antigen. , 1987, The New England journal of medicine.
[2] K. Slawin,et al. Seminal plasma contains “BPSA,” a molecular form of prostate‐specific antigen that is associated with benign prostatic hyperplasia , 2000, The Prostate.
[3] E. Diamandis,et al. Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. , 1995, Pharmacology & therapeutics.
[4] H. Lilja,et al. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. , 1995, Clinical chemistry.
[5] C. Belluco,et al. Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate , 2004, International journal of cancer.
[6] H. Lilja,et al. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. , 1997, Biochemical and biophysical research communications.
[7] Eleftherios P. Diamandis,et al. Human Kallikrein-related Peptidase 14 (KLK14) Is a New Activator Component of the KLK Proteolytic Cascade , 2008, Journal of Biological Chemistry.
[8] J Leinonen,et al. Prostate-specific antigen. , 1999, Seminars in cancer biology.
[9] H. Huland,et al. Molecular Heterogeneity of Free PSA in Sera of Patients with Benign and Malignant Prostate Tumors , 1999, European Urology.
[10] U. Stenman,et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. , 1991, Cancer research.
[11] N Heuzé,et al. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen. , 1999, Cancer research.
[12] H. Lilja,et al. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. , 1994, European journal of biochemistry.
[13] J. Clements,et al. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function? , 2006, Biological chemistry.
[14] Andrew J. Vickers,et al. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring , 2008, Nature Reviews Cancer.
[15] H. Lilja,et al. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. , 1987, The Journal of clinical investigation.
[16] O. Nilsson,et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. , 1991, Clinical chemistry.
[17] H. Lilja,et al. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. , 1992, The Journal of clinical investigation.
[18] H. Lilja,et al. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. , 1990, European journal of biochemistry.
[19] J. Gilabert,et al. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. , 1991, Thrombosis research.
[20] H. Lilja. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. , 1985, The Journal of clinical investigation.
[21] J. Hugosson,et al. Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146. , 2001, Clinical chemistry.
[22] H. Lilja,et al. Molecular cloning of human prostate specific antigen cDNA , 1987, FEBS letters.
[23] K. Watt,et al. Human prostate-specific antigen: structural and functional similarity with serine proteases. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[24] Mary Ann Comunale,et al. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. , 2009, Journal of proteome research.
[25] K. Fujikawa,et al. Characterization of the Precursor of Prostate-specific Antigen , 1997, The Journal of Biological Chemistry.